市售赭石、紫石英饮片质量考察及矿物药相关问题的探讨  

Investigation on quality of Haematitum and Fluoritum pieces in venalicium and study on related problems of mineral drugs

作　　者：石典花[1] 张军[1] 孙立立[1] 

机构地区：[1]山东省中医药研究院,山东济南250014

出　　处：《中国中药杂志》2015年第15期2979-2981,共3页China Journal of Chinese Materia Medica

基　　金：国家中医药行业专项(201007011);国家中医药管理局全国名老中医药专家传承工作室建设项目;山东省科技发展计划项目(2011-170)

摘　　要：通过市售赭石、紫石英饮片质量考察,探讨临床用矿物药生品饮片存在的主要问题。采用2010年版《中国药典》一部赭石、紫石英项下要求对市售赭石、紫石英饮片进行外观质量和内在质量考察。结果临床用矿物药外观和内在质量差异均较大,12批市售赭石饮片的不合格率达41.67%,13批紫石英饮片的不合格率达53.85%。建议药典明确矿物药粉碎粒度,进一步完善质量标准;药监系统加强检查和监管力度,以确保矿物药临床疗效的稳定性和可靠性。The main problems and solutions of mineral drugs in clinical use were studied based on the investigation on the quality of Haematitum and Fluoritum pieces in venalicium. The outward appearance and intrinsic quality of Haematitum and Fluoritum pieces in venalicium were studied by the requires which were in the first part of Chinese Pharmacopoeia published in 2010. The outward appearance and intrinsic quality of mineral drugs had large differences,the disqualification rate was 41. 67% in 12 batches of Haematitum pieces and the disqualification rate was 53. 85% in 13 batches of Fluoritum pieces. The crushing granularity of mineral drugs should be defined,the quality standards should be further improved. The drug adiministration ought to strengthen inspection and supervision in order to ensure the stability and reliability of the clinical efficacy.

关 键 词：赭石 紫石英 质量考察 矿物药 

分 类 号：R286.0[医药卫生—中药学]